Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
All OSSIOfiber implants are made with the same bio-integrative fiber matrix, a revolutionary advance in material science. Combining this highly differentiated technology with exceptional ...
Pleasanton, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing the next-generation ...
AMSBIO (Oxford, UK) announces an innovative range of induced pluripotent stem cell (iPSC) kits for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell ...
Researchers identified GSK3α as a key checkpoint controlling stem cell identity across multiple cell types. Inhibiting it ...
Rapid precision run-on sequencing (rPRO-seq) may help doctors understand disease states and treatment response in real time. Researchers at Sylvester Comprehensive Cancer Center (FL, USA) have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results